Newspaper Publication for opening of special window for re lodgment of transfer requests for physical shares and Second 100 days campaign Saksham Niveshak creating awareness amongst shareholders to update KYC Details and for shareholders engagement to prevent transfer of unpaid/unclaimed dividends to investor Education and Protection Fund (IEPF)
Annual Secretarial Compliance Report for Year ended 31st March 2026
Demand order from office of assistant commissioner, due to discrepancy in quantity as per invoice and quantity as per physical verification of Goods
Newspaper Publication for Audited Financials for the Q and Year ended 31.03.2026
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Sandu Pharmaceuticals Ltd 2 CIN NO. L24233GA1985PLC001587 3 Report filed for FY 2025-2026 Details of the Current block (all figures in Rs crore): 4 2 – year block period (Specify financial years)* NA 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T – 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T – 1) which was carried forward to FY(T)}(f) = (b) – [(c) – (e)]{ If the calculated value is zero or negative, write “nil”}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 – year Block period (Specify financial years)NA Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) – (e)}#0.00 Name of the Company Secretary :-PRATIKA MHAMBRAYDesignation :-COMPANY SECRETARY Name of the Chief Financial Officer :- VIJAY KAJAREKAR Designation : -CFO Date: 05/05/2026
Statement of Deviation and Variation of Funds for q ended 31.03.2026
Re-appointment of Internal Auditors and Cost Auditor for the FY 2026-27
Board Approves Final Dividend for the FY 2025-26
Audited financials for Q and Year ended 31.03.2026
Outcome of the Board Meeting dated 05th May 2026
| Particulars | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 16.76 | 17.09 | 15.26 | 17.66 | 16.61 | 17.43 | 15.60 | 17.05 | 17.70 | 14.07 |
| YOY Revenue Growth % | - | - | - | - | -0.93% | 1.97% | 2.18% | -3.46% | 6.61% | -19.28% |
| Other Income | 0.17 | 0.03 | 0.04 | 0.00 | 0.09 | 0.03 | 0.31 | 0.04 | 0.03 | 0.07 |
| Total Income | 16.93 | 17.12 | 15.31 | 17.66 | 16.69 | 17.46 | 15.91 | 17.09 | 17.73 | 14.14 |
| Total Expenses + | 16.05 | 16.42 | 14.93 | 17.45 | 15.93 | 17.08 | 15.19 | 16.82 | 17.00 | 13.80 |
| Cost of Materials Consumed | 2.59 | 3.06 | 3.17 | 1.98 | 2.62 | 2.42 | 2.84 | 2.27 | 2.44 | 3.01 |
| Employee Benefit Expense | 2.77 | 2.86 | 3.07 | 2.52 | 2.55 | 2.53 | 2.47 | 2.33 | 2.61 | 2.83 |
| Other Expenses | 4.38 | 5.94 | 5.49 | 5.33 | 4.94 | 5.76 | 6.32 | 5.01 | 6.03 | 5.02 |
| Operating Profit | 0.71 | 0.67 | 0.33 | 0.21 | 0.68 | 0.35 | 0.41 | 0.23 | 0.71 | 0.27 |
| OPM % | 4.2% | 3.9% | 2.2% | 1.2% | 4.1% | 2% | 2.6% | 1.3% | 4% | 1.9% |
| Profit Before Tax + | 0.88 | 0.70 | 0.38 | 0.21 | 0.76 | 0.38 | 0.72 | 0.27 | 0.74 | 0.34 |
| Tax Expense | 0.28 | 0.22 | 0.10 | 0.10 | 0.21 | 0.17 | 0.12 | 0.10 | 0.24 | 0.02 |
| Tax % | 31.8% | 31.1% | 27.8% | 48.1% | 28% | 45.4% | 17.3% | 38.4% | 32.8% | 4.7% |
| Profit After Tax | 0.60 | 0.48 | 0.27 | 0.11 | 0.55 | 0.21 | 0.59 | 0.17 | 0.50 | 0.33 |
| EPS (Basic) | 0.64 | 0.51 | 0.26 | 0.11 | 0.57 | 0.21 | 0.62 | 0.17 | 0.52 | 0.34 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Revenue from Operations | 67.19 | 67.28 | 65.35 |
| YOY Revenue Growth % | -0.13% | 2.96% | - |
| Other Income | 0.17 | 0.42 | 0.33 |
| Total Income | 67.36 | 67.70 | 65.68 |
| Total Expenses + | 65.20 | 65.63 | 63.46 |
| Cost of Materials Consumed | 10.12 | 9.85 | 11.13 |
| Employee Benefit Expense | 10.92 | 10.07 | 11.10 |
| Other Expenses | 21.41 | 22.34 | 20.58 |
| Operating Profit | 1.99 | 1.65 | 1.89 |
| OPM % | 3% | 2.5% | 2.9% |
| Profit Before Exceptional | 2.16 | 2.07 | 2.22 |
| Exceptional Items | 0.00 | 0.00 | 0.00 |
| Profit Before Tax + | 2.16 | 2.07 | 2.22 |
| Tax Expense | 0.61 | 0.61 | 0.70 |
| Tax % | 28.1% | 29.5% | 31.4% |
| Profit After Tax | 1.55 | 1.46 | 1.52 |
| EPS (Basic) | 1.60 | 1.51 | 1.61 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| ASSETS | |||
| Non-Current Assets + | 29.42 | 19.69 | 28.62 |
| Property, Plant & Equipment | 8.47 | 8.41 | 7.22 |
| Capital Work in Progress | 0.00 | 0.00 | 0.42 |
| Non-Current Investments | 0.00 | 0.00 | 9.65 |
| Goodwill | 0.00 | 0.00 | 0.00 |
| Other Intangible Assets | 0.02 | 0.03 | 0.05 |
| Current Assets + | 26.30 | 32.72 | 25.55 |
| Inventories | 14.15 | 12.25 | 14.33 |
| Trade Receivables | 4.76 | 4.87 | 4.79 |
| Cash and Cash Equivalents | 1.30 | 1.00 | 2.28 |
| Current Investments | 0.00 | 10.42 | 0.00 |
| LIABILITIES & EQUITY | |||
| Total Equity | 42.02 | 40.59 | 39.24 |
| Equity Share Capital | 9.66 | 9.66 | 9.66 |
| Other Equity | 32.36 | 30.93 | 29.58 |
| Non-Current Liabilities | 1.62 | 1.18 | 1.04 |
| Current Liabilities | 12.09 | 10.64 | 13.88 |
| Total Liabilities | 13.70 | 11.82 | 14.93 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash from Operating Activities | 0.95 | 0.76 | 0.22 |
| Cash from Investing Activities | -0.19 | -1.31 | 0.54 |
| Cash from Financing Activities | -0.46 | -0.72 | 0.58 |
| Net Increase/Decrease in Cash | 0.30 | -1.27 | 1.34 |